Daniel Öhlund

Umeå University — Sweden

Medicine · Health Sciences

24h-index8.0kcitations215works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(104), Epigenetics and DNA Methylation(28), Genetics and Neurodevelopmental Disorders(26), Cancer Cells and Metastasis(25), Pancreatic function and diabetes(24)

Publications215 total

New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer
British Journal of Cancer·2025Open Access
Supplementary file 2 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure 1 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure 5 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary file 4 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary Tables from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure 6 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary Figures 1-5 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary file 1 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary file 3 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure 4 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary Figure Legends from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure 3 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Supplementary file 5 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure 2 from Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
2025Open Access
Figure S1 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
2025Open Access
Figure S4 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
2025Open Access
Figure S2 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
2025Open Access
Figure S3 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
2025Open Access
Figure S5 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
2025Open Access
page 1 of 11Next →

Frequent Co-authors

Malin Sund(16), David A. Tuveson(15), Oskar Franklin(12), Mariano Ponz‐Sarvisé(8), Christina Lundin(8), Giulia Biffi(7), Ela Elyada(7), Youngkyu Park(7), Vincenzo Corbo(6), Iok In Christine Chio(6), James Mason(6), Abram Handly-Santana(5), Tobiloba E. Oni(5), Chang‐Il Hwang(5), Hervé Tiriac(5), Erik Lundberg(5), Peter Naredi(5), Mitesh Dongre(5), Cédric Patthey(5), Lindsey A. Baker(4)